Literature DB >> 11500390

Predominance of serotype-specific mucosal antibody response in Shigella flexneri-infected humans living in an area of endemicity.

V Rasolofo-Razanamparany1, A M Cassel-Beraud, J Roux, P J Sansonetti, A Phalipon.   

Abstract

The mucosal humoral immune response elicited following Shigella flexneri infection in patients living in Antananarivo districts (Madagascar Island) was evaluated by measuring the gut-derived, circulating immunoglobulin A (IgA) antibody-secreting cells (ASC) specific for the major bacterial antigen lipopolysaccharide (LPS). Fifty, 34, 11, and 5% of the S. flexneri-positive patients were infected with serotypes 2a, 1a, 4a, and 3a, respectively. The total number of IgA ASC in infected patients increased significantly, compared to the number in healthy controls, early after the onset of disease. The number of anti-homologous LPS IgA ASC varied among individuals and peaked between days 5 and 10 after the onset of the disease. In the S. flexneri 1a- and 2a-infected patients, the level of IgA ASC cross-reactivity to heterologous S. flexneri serotypes was weak. These data indicate that S. flexneri 2a and 1a are the predominant strains responsible for shigellosis in this area of endemicity and that the anti-LPS antibody response following natural infection is mainly directed against serotype-specific determinants.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11500390      PMCID: PMC98630          DOI: 10.1128/IAI.69.9.5230-5234.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Immune response to acute diarrhea seen as circulating antibody-secreting cells.

Authors:  A M Kantele; R Takanen; H Arvilommi
Journal:  J Infect Dis       Date:  1988-11       Impact factor: 5.226

Review 2.  Zinc deficiency, malnutrition and the gastrointestinal tract.

Authors:  R A Wapnir
Journal:  J Nutr       Date:  2000-05       Impact factor: 4.798

3.  [Development of antibiotic resistance of type 1 Shigella dysenteriae strains (Shiga bacillus) isolated in Tananarive on the East coast of Madagascar].

Authors:  A M Cassel-Beraud; P Coulanges; C Richard
Journal:  Arch Inst Pasteur Madagascar       Date:  1989

4.  A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells.

Authors:  J D Sedgwick; P G Holt
Journal:  J Immunol Methods       Date:  1983-02-25       Impact factor: 2.303

Review 5.  The lipopolysaccharide of Shigella bacteria as a virulence factor.

Authors:  A A Lindberg; A Kärnell; A Weintraub
Journal:  Rev Infect Dis       Date:  1991 Mar-Apr

6.  Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602.

Authors:  T S Coster; C W Hoge; L L VanDeVerg; A B Hartman; E V Oaks; M M Venkatesan; D Cohen; G Robin; A Fontaine-Thompson; P J Sansonetti; T L Hale
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

7.  Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.

Authors:  K L Kotloff; J P Winickoff; B Ivanoff; J D Clemens; D L Swerdlow; P J Sansonetti; G K Adak; M M Levine
Journal:  Bull World Health Organ       Date:  1999       Impact factor: 9.408

8.  Immune responses in Vietnamese children after a single dose of the auxotrophic, live Shigella flexneri Y vaccine strain SFL124.

Authors:  A Li; P D Cam; D Islam; N B Minh; P T Huan; Z C Rong; K Karlsson; G Lindberg; A A Lindberg
Journal:  J Infect       Date:  1994-01       Impact factor: 6.072

9.  Safety and immunogenicity study of the auxotrophic Shigella flexneri 2a vaccine SFL1070 with a deleted aroD gene in adult Swedish volunteers.

Authors:  A Kärnell; A Li; C R Zhao; K Karlsson; B M Nguyen; A A Lindberg
Journal:  Vaccine       Date:  1995-01       Impact factor: 3.641

10.  Presence of specific immunoglobulin A-secreting cells in peripheral blood after natural infection with Shigella sonnei.

Authors:  N Orr; G Robin; G Lowell; D Cohen
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

View more
  13 in total

Review 1.  Use of Pathogen-Specific Antibody Biomarkers to Estimate Waterborne Infections in Population-Based Settings.

Authors:  Natalie G Exum; Nora Pisanic; Douglas A Granger; Kellogg J Schwab; Barbara Detrick; Margaret Kosek; Andrey I Egorov; Shannon M Griffin; Christopher D Heaney
Journal:  Curr Environ Health Rep       Date:  2016-09

2.  Co-administration of rIpaB domain of Shigella with rGroEL of S. Typhi enhances the immune responses and protective efficacy against Shigella infection.

Authors:  Sekar Tamil Selvi Chitradevi; Gurpreet Kaur; Sivaramakrishna Uppalapati; Anandprakash Yadav; Dependrapratap Singh; Anju Bansal
Journal:  Cell Mol Immunol       Date:  2015-02-02       Impact factor: 11.530

3.  Characterization of a multicomponent live, attenuated Shigella flexneri vaccine.

Authors:  BreOnna C DeLaine; Tao Wu; Christen L Grassel; Avital Shimanovich; Marcela F Pasetti; Myron M Levine; Eileen M Barry
Journal:  Pathog Dis       Date:  2016-04-21       Impact factor: 3.166

4.  Circulating Gut-Homing (α4β7+) Plasmablast Responses against Shigella Surface Protein Antigens among Hospitalized Patients with Diarrhea.

Authors:  Anuradha Sinha; Ayan Dey; Giulietta Saletti; Pradip Samanta; Partha Sarathi Chakraborty; M K Bhattacharya; Santanu Ghosh; T Ramamurthy; Jae-Ouk Kim; Jae Seung Yang; Dong Wook Kim; Cecil Czerkinsky; Ranjan K Nandy
Journal:  Clin Vaccine Immunol       Date:  2016-07-05

5.  Characterization of a novel fusion protein from IpaB and IpaD of Shigella spp. and its potential as a pan-Shigella vaccine.

Authors:  Francisco J Martinez-Becerra; Xiaotong Chen; Nicholas E Dickenson; Shyamal P Choudhari; Kelly Harrison; John D Clements; William D Picking; Lillian L Van De Verg; Richard I Walker; Wendy L Picking
Journal:  Infect Immun       Date:  2013-09-23       Impact factor: 3.441

6.  Agglutinating secretory IgA preserves intestinal epithelial cell integrity during apical infection by Shigella flexneri.

Authors:  Amandine Mathias; Stéphanie Longet; Blaise Corthésy
Journal:  Infect Immun       Date:  2013-06-10       Impact factor: 3.441

7.  Transient suppression of Shigella flexneri type 3 secretion by a protective O-antigen-specific monoclonal IgA.

Authors:  Stephen J Forbes; Tia Bumpus; Elizabeth A McCarthy; Blaise Corthésy; Nicholas J Mantis
Journal:  mBio       Date:  2011-05-24       Impact factor: 7.867

8.  The human intestinal IgA response; burning questions.

Authors:  Jo Spencer; Linda S Klavinskis; Louise D Fraser
Journal:  Front Immunol       Date:  2012-05-11       Impact factor: 7.561

9.  Shigella flexneri: a three-year antimicrobial resistance monitoring of isolates in a Children Hospital, Ahvaz, Iran.

Authors:  Soheila Khaghani; Ahmad Shamsizadeh; Roya Nikfar; Ali Hesami
Journal:  Iran J Microbiol       Date:  2014-08

10.  Clinical Trial of an Oral Live Shigella sonnei Vaccine Candidate, WRSS1, in Thai Adults.

Authors:  Punnee Pitisuttithum; Dilara Islam; Supat Chamnanchanunt; Nattaya Ruamsap; Patchariya Khantapura; Jaranit Kaewkungwal; Chatporn Kittitrakul; Viravarn Luvira; Jittima Dhitavat; Malabi M Venkatesan; Carl J Mason; Ladaporn Bodhidatta
Journal:  Clin Vaccine Immunol       Date:  2016-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.